Evolution of the Average Target: Doximity, Inc.

Evolution of the Average Target - Doximity, Inc.

Evolution of the Target Price: Doximity, Inc.

Evolution of the Target Price - Doximity, Inc.

Changes in Analyst Recommendations: Doximity, Inc.

301e324c4b5.yoFmq_Vizd3RkSg0e_0kdYNiaNRGJ1SIxVn5dAfJ8vc.rbcV7KUTh5ibzlJ7KbpMTfM4IoECfjbhhBGRTCqlnMSj9zHEzBiZp6XpcQ~8e165ea5de4ce260887063b920f050e7
07:54am BofA Securities Adjusts Price Target on Doximity to $23 From $20, Maintains Underperform Rating MT
08-13 Truist Adjusts Price Target on Doximity to $24 From $19, Maintains Hold Rating MT
08-10 Wells Fargo Downgrades Doximity to Underweight From Equalweight, Price Target is $18 MT
08-07 Doximity Raises FY27 Outlook on AI Search Momentum, RBC Says MT
06-29 Doximity's AI Pivot Clouds Growth Trajectory, May Face Execution Risks, BofA Says in Downgrade MT
06-29 BofA Downgrades Doximity to Underperform From Buy, Cuts Price Target to $20 From $38 MT
06-29 Doximity Facing Limited Clarity on AI Projects, BofA Says MT
06-29 BofA Downgrades Doximity to Underperform From Buy, Price Target is $20 MT
06-25 Doximity Faces Continued Softness in Pharma Marketing Spending, RBC Capital Markets Says MT
05-15 Barclays Downgrades Doximity to Equalweight From Overweight, Adjusts Price Target to $20 From $38 MT
05-15 Analyst recommendations: Amex, Applied Materials, Doximity, Fox, Broadcom… Zonebourse
05-14 Doximity Growth Slowdown, Weak Outlook Raise Concerns, Morgan Stanley Says MT
05-14 KeyBanc Downgrades Doximity to Sector Weight From Overweight MT
05-14 Jefferies Downgrades Doximity to Hold From Buy, Adjusts Price Target to $19 From $51 MT
05-14 Wells Fargo Downgrades Doximity to Equal Weight From Overweight, Cuts Price Target to $18 From $32 MT
05-14 Baird Downgrades Doximity to Neutral From Outperform, Adjusts Price Target to $18 From $40 MT
05-14 BTIG Downgrades Doximity to Neutral From Buy MT
05-14 Morgan Stanley Cuts Price Target on Doximity to $35 From $49, Keeps Overweight Rating MT
05-14 Truist Securities Adjusts Price Target on Doximity to $19 From $29, Maintains Hold Rating MT
05-14 Analyst recommendations: Doximity, Reddit, Cisco, Whirlpool, Caterpillar… Zonebourse
05-11 Analyst recommendations: Biomarin Pharmaceuticals, Walt Disney, Apollo Global Management, Datadog, Roku… Zonebourse
04-20 Truist Downgrades Doximity to Hold From Buy, Cuts Price Target to $29 From $37 MT
04-20 Analyst recommendations: Doximity, Okta, Bloom Energy, Intel, Whirlpool… Zonebourse
04-13 Analyst recommendations: ConocoPhillips, Hewlett Packard Enterprise, Nike, Occidental Petroleum, T-Mobile, Ge Vernova… Zonebourse
04-08 Doximity Shares Fall After Evercore Downgrade MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+12.32%
+6.32%
+83.17%
+14.86%
+7.94%
+7.91%
+5.25%
-2.1%
+10.21%
Average +16.21%
Weighted average by Cap. +15.76%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
31.45USD
Average target price
31.11USD
Spread / Average Target
-1.08%
High Price Target
47.00USD
Spread / Highest target
+49.44%
Low Price Target
18.00USD
Spread / Lowest Target
-42.77%

Analyst Consensus Detail

Analyst consensus - Doximity, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Doximity, Inc.
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Doximity, Inc.